在sarcoma中向前推进,新的TCR针对NY-ESO-1
Rusul Al-Marayaty1, Seth M Pollack1
1Northwestern University, Feinberg School of Medicine, Department of Medicine, Division of Oncology, Chicago, IL, USA.
Cell reports. Medicine
|August 16, 2023
概括
这一第一阶段试验表明,新型NY-ESO-1-特异性T细胞受体 (TCR) -T细胞是安全有效的. 这代表了采用T细胞治疗在高级软组织肉瘤中取得的重大进展.
科学领域:
- 在瘤学瘤学.
- 免疫治疗是一种免疫疗法.
- 细胞疗法 细胞疗法
背景情况:
- 先进的软组织肉瘤的治疗具有挑战性.
- 采用T细胞疗法为癌症治疗提供了一个有前途的途径.
研究的目的:
- 评估新型NY-ESO-1特异性TCR-T细胞的安全性和有效性.
- 评估这种治疗在晚期软组织肉瘤中的潜力.
主要方法:
- 一期临床试验. 一期临床试验.
- 使用NY-ESO-1-特异性TCR-T细胞.
- 对安全性和有效性终点的评估.
主要成果:
- 证明了新型TCR-T细胞疗法的安全性.
- 在患有晚期软组织肉瘤的患者中显示出有效性.
结论:
- 特定于NY-ESO-1的TCR-T细胞是一种安全有效的治疗选择.
- 这种疗法标志着在临床实践中采用T细胞疗法的重大进步.
更多相关视频
相关概念视频
02:56Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K
02:57Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K
01:27Tumor Immunotherapy
557
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
557
02:07Tumor Progression
6.4K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.4K